New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2014
09:06 EDTFRXForest Labs makes $40M milestone payment to Adamas Pharma
Forest Laboratories has made a $40M milestone payment to Adamas Pharmaceuticals for MDX-8704, a fixed dosed combination of Namenda XR (memantine HCl extended release capsules) and donepezil HCl being developed as a once daily therapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the U.S., for which Forest has exclusive US commercialization rights. The milestone payments are for the successful completion of studies that support the planned New Drug Application filing for MDX-8704 by Forest in 1H14.
News For FRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for FRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use